Side effects and safety basics (what to know before starting) Like injectable GLP-1s, Wegovy tablets can cause gastrointestinal side effects (nausea, reflux, constipation/diarrhea), especially during dose escalation
Another clinical trial involving over 1,000 people with type 2 diabetes and a body mass index (BMI) of 27 or higher also showed that semaglutide was effective in promoting weight loss
Once-Weekly Semaglutide in Adults With Overweight or Obesity (March 2021) Wegovy Dosing Schedule Ozempic Dosing Schedule Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial (February 24, 2021) Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial (October 10, 2022) Weight Loss Outcomes Associated With Semaglutide Treatment for Patients With Overweight or Obesity (September 19, 2022) Wegovy Side Effects Ozempic Side Effects WEGOVY (semaglutide) Injection, For Subcutaneous Use
Understanding the Basics: Semaglutide and Tirzepatide Semaglutide: A GLP-1 receptor agonist, Semaglutide, originally introduced for managing type 2 diabetes, belongs to the class of incretin mimetics